Emerging efficacy data have led to the emergency use authorization or approval of COVID-
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …

Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Simple Summary Although COVID-19 vaccine side effects are generally well tolerated,
information on cancer patients is lacking due to their exclusion from original clinical trials …

Patients with cancer are among the most vulnerable groups of the COVID-19 pandemic,
whereas vaccinations can represent a cornerstone in overcoming the pandemic itself …

Abstract Coronavirus disease 2019 (COVID-19) has affected more than 96 million people
worldwide, leading the World Health Organization (WHO) to declare a pandemic in March …

Background Vaccination is an important preventive health measure to protect against
symptomatic and severe COVID-19. Impaired immunity secondary to an underlying …

Published series on COVID-19 support the notion that patients with cancer are a particularly
vulnerable population. There is a confluence of risk factors between cancer and COVID-19 …

Background Efficacy and safety data of COVID-19 vaccines among cancer populations have
been limited; however, preliminary data from recent studies have emerged regarding their …

Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

Background People with cancer are at increased risk of hospitalisation and death following
infection with SARS-CoV-2. Therefore, we aimed to conduct one of the first evaluations of …